NYSE:CVD - Covance Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$107.07Today's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Covance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services. Receive CVD News and Ratings via Email Sign-up to receive the latest news and ratings for CVD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryLife Sciences Tools & Services SectorN/A Current SymbolNYSE:CVD Previous Symbol CUSIP22281610 CIK1023131 Webwww.covance.com Phone+1-609-4524440Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Covance (NYSE:CVD) Frequently Asked Questions What is Covance's stock symbol? Covance trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVD." How were Covance's earnings last quarter? Covance Inc. (NYSE:CVD) announced its quarterly earnings data on Wednesday, February, 4th. The healthcare company reported $0.97 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.97. The healthcare company had revenue of $634 million for the quarter, compared to analysts' expectations of $631.30 million. View Covance's Earnings History. Has Covance been receiving favorable news coverage? News coverage about CVD stock has been trending somewhat positive recently, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Covance earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave media headlines about the healthcare company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. What other stocks do shareholders of Covance own? Based on aggregate information from My MarketBeat watchlists, some companies that other Covance investors own include Allena Pharmaceuticals (ALNA), Laboratory Corp. of America (LH), Arbutus Biopharma (ABUS), Catalyst Biosciences (CBIO), Cisco Systems (CSCO), Fate Therapeutics (FATE), Flexion Therapeutics (FLXN), Genocea Biosciences (GNCA), GTX (GTXI) and REDHILL BIOPHAR/S (RDHL). How do I buy shares of Covance? Shares of CVD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Covance's official website? The official website for Covance is http://www.covance.com. How can I contact Covance? Covance's mailing address is 210 Carnegie Ctr, PRINCETON, NJ 08540-6233, United States. The healthcare company can be reached via phone at +1-609-4524440. MarketBeat Community Rating for Covance (NYSE CVD)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 225 (Vote Outperform)Underperform Votes: 262 (Vote Underperform)Total Votes: 487MarketBeat's community ratings are surveys of what our community members think about Covance and other stocks. Vote "Outperform" if you believe CVD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/22/2019 by MarketBeat.com StaffFeatured Article: Why is cost of goods sold important?